Global pharmaceutical giant Gilead Sciences — which has a major presence in Cork — agreed to buy Kite Pharma in a nearly $12bn (€10bn) deal, writes Natalie Grover and Michael Erman.

International groups representing doctors and patients have launched a fresh challenge to the patent on Gilead Sciences’ hepatitis C drug Sofosbuvir at the European Patent Office in order to increase access to the treatment.